EquityZen Growth Technology Fund LLC - Series 316
Raised
$316K
Investors
18
Min Invest
$10,000
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 316 is a Delaware pooled investment vehicle filed November 21, 2018, that raised $316K from 18 investors under Rule 506(b) and Section 3(c)(1). The entity is part of the EquityZen platform, a pre-IPO secondary market operator with over 1,800 related EDGAR entities, managed by EquityZen Advisors LLC with a $10K minimum investment.
This pre-IPO fund vehicle uses the standard 506(b)/3(c)(1) exemption pattern typical of private secondary market platforms, with an accessible $10K minimum that allows retail accredited investors to participate in pre-IPO equity exposure. The per-investor average of approximately $17.6K reflects EquityZen's deal-by-deal SPV model where individual investors pool capital to acquire shares in a single private company.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Shriram Bhashyam
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
